HAMADA; Hirofumi

Patent Applications and Registrations

Patent applications and USPTO patent grants for HAMADA; Hirofumi.The latest application filed is for "antibody-pyrrolobenzodiazepine derivative conjugate".

Company Profile

5.11.23

HAMADA; Hirofumi - Tokyo JP
HAMADA; Hirofumi - Sapporo-shi JP
Hamada; Hirofumi - Sapporo JP
Hamada; Hirofumi - Kanagawa JP
Hamada; Hirofumi - Ebina JP
HAMADA; Hirofumi - Ebina-shi JP
HAMADA; Hirofumi - Hokkaido JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody-pyrrolobenzodiazepine Derivative Conjugate App 20220125943 - TODA; Narihiro ; et al.	2022-04-28
Anti-trop2 Antibody-drug Conjugate App 20210238303 - AGATSUMA; Toshinori ; et al.	2021-08-05
Anti-TROP2 antibody-drug conjugate Grant 11,008,398 - Agatsuma , et al. May 18, 2	2021-05-18
Bearing component, rotating device using the same, and image forming apparatus Grant 10,908,525 - Kuramoto , et al. February 2, 2	2021-02-02
Bearing Component, Rotating Device Using The Same, And Image Forming Apparatus App 20200319572 - KURAMOTO; Kazuki ; et al.	2020-10-08
Antibody-pyrrolobenzodiazepine Derivative Conjugate App 20200261594 - TODA; Narihiro ; et al.	2020-08-20
Image forming apparatus Grant 10,564,581 - Kuramoto , et al. Feb	2020-02-18
Anti-trop2 Antibody-drug Conjugate App 20190144559 - Agatsuma; Toshinori ; et al.	2019-05-16
Anti-TROP2 antibody-drug conjugate Grant 10,227,417 - Agatsuma , et al.	2019-03-12
Anti-trop2 Antibody-drug Conjugate App 20180094073 - AGATSUMA; Toshinori ; et al.	2018-04-05
Image forming apparatus, method, non-transitory computer readable medium, and detachable body Grant 9,915,902 - Hamada , et al. March 13, 2	2018-03-13
Anti-TROP2 antibody-drug conjugate Grant 9,850,312 - Agatsuma , et al. December 26, 2	2017-12-26
Image forming apparatus and image forming method Grant 9,846,382 - Makiura , et al. December 19, 2	2017-12-19
Image Forming Apparatus, Method, Non-transitory Computer Readable Medium, And Detachable Body App 20170242381 - HAMADA; Hirofumi ; et al.	2017-08-24
Image forming apparatus, image forming method, and non-transitory computer readable medium Grant 9,720,344 - Hamada August 1, 2	2017-08-01
Image Forming Apparatus And Image Forming Method App 20170205727 - MAKIURA; Shinya ; et al.	2017-07-20
Anti-trop2 Antibody-drug Conjugate App 20160297890 - AGATSUMA; Toshinori ; et al.	2016-10-13
Image forming apparatus Grant 9,014,588 - Hamada April 21, 2	2015-04-21
Image Forming Apparatus App 20140023384 - HAMADA; Hirofumi	2014-01-23
Anti-trop-2 Antibody App 20120237518 - YAMAGUCHI; Miki ; et al.	2012-09-20
Antibody directed against PAP2a and use thereof for diagnostic and therapeutic purposes Grant 8,232,069 - Hamada , et al. July 31, 2	2012-07-31
Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient Grant 7,968,088 - Honmou , et al. June 28, 2	2011-06-28
Method For Inducing Differentiation Of Mesodermal Stem Cells, Es Cells, Or Immortalized Mesodermal Stem Cells Into Neural Cells App 20090280564 - HONMOU; Osamu ; et al.	2009-11-12
ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES App 20090214421 - Hamada; Hirofumi ; et al.	2009-08-27
Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient App 20080286246 - Honmou; Osamu ; et al.	2008-11-20
Differentiation of Cd34 Positive Cell to Megakaryocyte and Multiplication App 20080233643 - Matsunaga; Takuya ; et al.	2008-09-25
Internally administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient App 20070178591 - Honmou; Osamu ; et al.	2007-08-02
Remedy for prion disease and method of producing the same App 20070160585 - Fujinaga; Kei ; et al.	2007-07-12
Method for treating ischemic diseases App 20070036756 - Hamada; Hirofumi ; et al.	2007-02-15
Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient App 20060210544 - Honmou; Osamu ; et al.	2006-09-21
Therapeutic autologous-cell delivery support system, financial system for use therewith, and method therefor App 20060062771 - Sasaki; Nobuo ; et al.	2006-03-23
Immortalized mesenchymal cells and utilization thereof App 20050084959 - Hamada, Hirofumi ; et al.	2005-04-21
Method for inducing differentiation mesodermal stem cells, es cells or immortalized cells into nervous system cells App 20040259254 - Honmou, Osamu ; et al.	2004-12-23
Method for treatment of vascular regeneration App 20040234502 - Hamada, Hirofumi ; et al.	2004-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.